Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study

Divya A. Parikh; Ali Raza Khaki; Stephen B. Williams

doi:10.1016/j.eururo.2022.01.016

Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study

Divya A. Parikh, Ali Raza Khaki, Stephen B. Williams

Surgery

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	429-430
Number of pages	2
Journal	European Urology
Volume	81
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2022.01.016
State	Published - Apr 2022

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2022.01.016

Cite this

Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study. / Parikh, Divya A.; Khaki, Ali Raza; Williams, Stephen B.
In: European Urology, Vol. 81, No. 4, 04.2022, p. 429-430.

Research output: Contribution to journal › Comment/debate › peer-review

@article{ebd98c930160475d84a3ebc83dff9c45,

title = "Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study",

author = "Parikh, {Divya A.} and Khaki, {Ali Raza} and Williams, {Stephen B.}",

year = "2022",

month = apr,

doi = "10.1016/j.eururo.2022.01.016",

language = "English (US)",

volume = "81",

pages = "429--430",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Re

T2 - Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study

AU - Parikh, Divya A.

AU - Khaki, Ali Raza

AU - Williams, Stephen B.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124150330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124150330&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2022.01.016

DO - 10.1016/j.eururo.2022.01.016

M3 - Comment/debate

C2 - 35131115

AN - SCOPUS:85124150330

SN - 0302-2838

VL - 81

SP - 429

EP - 430

JO - European Urology

JF - European Urology

IS - 4

ER -

Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this